Additionally, methods to detect NLRP3 ubiquitination levels in peripheral blood mononuclear cells, such as immunoprecipitation-mass spectrometry combined techniques, can be developed to assess Parkin functional status, providing warning markers for the prodromal phase of PD. This evidence concerns the gene NLRP3 and Parkinson disease.